Baird Medical Investment Holdings Limited (BDMD)
NASDAQ: BDMD · Real-Time Price · USD
2.980
+0.700 (30.70%)
At close: Feb 27, 2026, 4:00 PM EST
2.890
-0.090 (-3.02%)
After-hours: Feb 27, 2026, 7:58 PM EST
BDMD Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Revenue | 31.86 | 37.04 | 31.46 | 35.09 | 29.7 | 18.12 | Upgrade
|
| Revenue Growth (YoY) | -3.60% | 17.73% | -10.35% | 18.16% | 63.92% | 48.37% | Upgrade
|
| Cost of Revenue | 4.16 | 4.38 | 4.23 | 7.05 | 5.03 | 2.51 | Upgrade
|
| Gross Profit | 27.7 | 32.65 | 27.23 | 28.04 | 24.67 | 15.61 | Upgrade
|
| Selling, General & Admin | 16.6 | 11.16 | 11.09 | 10.55 | 8.64 | 4.6 | Upgrade
|
| Research & Development | 11.33 | 6.17 | 4.27 | 3.86 | 1.54 | 0.75 | Upgrade
|
| Other Operating Expenses | - | - | - | - | 0.31 | 0.19 | Upgrade
|
| Operating Expenses | 27.92 | 17.34 | 15.37 | 14.41 | 10.07 | 5.94 | Upgrade
|
| Operating Income | -0.22 | 15.32 | 11.86 | 13.63 | 14.6 | 9.67 | Upgrade
|
| Interest Expense | -0.7 | -0.58 | -0.29 | -0.3 | -0.15 | -0.16 | Upgrade
|
| Interest & Investment Income | 0 | 0 | 0 | 0.01 | 0 | 0 | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | - | - | 0.05 | - | Upgrade
|
| Other Non Operating Income (Expenses) | -0.52 | -0.65 | 0.78 | 1.18 | -0.98 | -3.77 | Upgrade
|
| EBT Excluding Unusual Items | -1.44 | 14.09 | 12.36 | 14.52 | 13.52 | 5.74 | Upgrade
|
| Other Unusual Items | - | - | - | - | 0.79 | 3.84 | Upgrade
|
| Pretax Income | -1.44 | 14.09 | 12.36 | 14.52 | 14.32 | 9.58 | Upgrade
|
| Income Tax Expense | 1.57 | 1.49 | 1.7 | 1.75 | 2.53 | 2.43 | Upgrade
|
| Earnings From Continuing Operations | -3.01 | 12.6 | 10.66 | 12.77 | 11.78 | 7.15 | Upgrade
|
| Minority Interest in Earnings | -0.17 | -0.14 | -0.11 | -0.21 | -0.1 | -0.05 | Upgrade
|
| Net Income | -3.17 | 12.45 | 10.55 | 12.57 | 11.68 | 7.1 | Upgrade
|
| Net Income to Common | -3.17 | 12.45 | 10.55 | 12.57 | 11.68 | 7.1 | Upgrade
|
| Net Income Growth | - | 18.09% | -16.09% | 7.60% | 64.54% | - | Upgrade
|
| Shares Outstanding (Basic) | 26 | 26 | 26 | 26 | 1,181 | - | Upgrade
|
| Shares Outstanding (Diluted) | 26 | 26 | 26 | 26 | 1,181 | - | Upgrade
|
| Shares Change (YoY) | 9.96% | 0.29% | - | -97.84% | - | - | Upgrade
|
| EPS (Basic) | -0.12 | 0.49 | 0.41 | 0.49 | 0.01 | - | Upgrade
|
| EPS (Diluted) | -0.12 | 0.49 | 0.41 | 0.49 | 0.01 | - | Upgrade
|
| EPS Growth | - | 18.86% | -16.33% | 4853.49% | - | - | Upgrade
|
| Free Cash Flow | -7.96 | -9.17 | -3.66 | -5.42 | 5.92 | 3.25 | Upgrade
|
| Free Cash Flow Per Share | -0.31 | -0.36 | -0.14 | -0.21 | 0.01 | - | Upgrade
|
| Gross Margin | 86.94% | 88.17% | 86.56% | 79.90% | 83.08% | 86.14% | Upgrade
|
| Operating Margin | -0.70% | 41.35% | 37.71% | 38.85% | 49.16% | 53.38% | Upgrade
|
| Profit Margin | -9.95% | 33.62% | 33.52% | 35.82% | 39.33% | 39.18% | Upgrade
|
| Free Cash Flow Margin | -24.98% | -24.75% | -11.63% | -15.46% | 19.95% | 17.94% | Upgrade
|
| EBITDA | 0.92 | 16.45 | 12.88 | 14.55 | 15.42 | 10.28 | Upgrade
|
| EBITDA Margin | 2.89% | 44.43% | 40.93% | 41.46% | 51.91% | 56.74% | Upgrade
|
| D&A For EBITDA | 1.14 | 1.14 | 1.01 | 0.92 | 0.82 | 0.61 | Upgrade
|
| EBIT | -0.22 | 15.32 | 11.86 | 13.63 | 14.6 | 9.67 | Upgrade
|
| EBIT Margin | -0.70% | 41.35% | 37.71% | 38.85% | 49.16% | 53.38% | Upgrade
|
| Effective Tax Rate | - | 10.57% | 13.76% | 12.03% | 17.69% | 25.32% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.